Drug
Topotecan
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Haematotoxicity | 86 | 32.4 | 32.8 | signal |
| 2 | Febrile Neutropenia | 426 | 22.4 | 24.0 | signal |
| 3 | Ovarian Cancer | 58 | 21.8 | 22.0 | signal |
| 4 | Acute Myeloid Leukaemia | 90 | 20.1 | 20.4 | signal |
| 5 | Therapy Partial Responder | 78 | 18.0 | 18.2 | signal |
| 6 | Lymphopenia | 71 | 17.5 | 17.7 | signal |
| 7 | Neutrophil Count Decreased | 192 | 16.5 | 17.0 | signal |
| 8 | Mucosal Inflammation | 123 | 16.4 | 16.7 | signal |
| 9 | Bronchospasm | 66 | 16.0 | 16.2 | signal |
| 10 | Bone Marrow Failure | 89 | 15.1 | 15.3 | signal |
| 11 | Pancytopenia | 236 | 14.7 | 15.3 | signal |
| 12 | Myelodysplastic Syndrome | 60 | 14.4 | 14.5 | signal |
| 13 | Metastases To Liver | 70 | 13.9 | 14.0 | signal |
| 14 | Ileus | 49 | 13.8 | 13.9 | signal |
| 15 | Disease Progression | 436 | 12.8 | 13.8 | signal |
| 16 | Ascites | 107 | 12.6 | 12.8 | signal |
| 17 | Thrombocytopenia | 402 | 12.5 | 13.3 | signal |
| 18 | Neutropenia | 484 | 12.4 | 13.4 | signal |
| 19 | Red Blood Cell Count Decreased | 100 | 12.1 | 12.3 | signal |
| 20 | Neoplasm Progression | 120 | 11.9 | 12.1 | signal |
| 21 | Metastases To Central Nervous System | 41 | 11.1 | 11.2 | signal |
| 22 | Malignant Neoplasm Progression | 299 | 10.2 | 10.7 | signal |
| 23 | Metastases To Bone | 48 | 10.2 | 10.3 | signal |
| 24 | Leukopenia | 137 | 9.5 | 9.7 | signal |
| 25 | Anaemia | 509 | 9.2 | 10.0 | signal |
| 26 | White Blood Cell Count Decreased | 281 | 9.0 | 9.4 | signal |
| 27 | Eyelid Oedema | 30 | 8.9 | 8.9 | signal |
| 28 | Drug Toxicity | 34 | 8.5 | 8.6 | signal |
| 29 | Hypomagnesaemia | 34 | 8.5 | 8.5 | signal |
| 30 | Drug Resistance | 62 | 8.4 | 8.4 | signal |
| 31 | Retinal Detachment | 22 | 8.3 | 8.3 | signal |
| 32 | Platelet Count Decreased | 249 | 8.1 | 8.4 | signal |
| 33 | Posterior Reversible Encephalopathy Syndrome | 22 | 8.0 | 8.0 | signal |
| 34 | Anorexia | 30 | 8.0 | 8.0 | signal |
| 35 | Eyelid Ptosis | 23 | 7.8 | 7.9 | signal |
| 36 | Hypotonia | 22 | 7.6 | 7.6 | signal |
| 37 | Cytopenia | 26 | 7.5 | 7.6 | signal |
| 38 | Blood Lactate Dehydrogenase Increased | 34 | 7.4 | 7.4 | signal |
| 39 | Metastases To Lung | 24 | 7.2 | 7.2 | signal |
| 40 | Small Intestinal Obstruction | 25 | 7.1 | 7.1 | signal |
| 41 | Hospice Care | 20 | 7.0 | 7.1 | signal |
| 42 | Intestinal Perforation | 22 | 6.8 | 6.8 | signal |
| 43 | Thrombotic Microangiopathy | 18 | 6.4 | 6.5 | signal |
| 44 | Hypokalaemia | 79 | 6.0 | 6.0 | signal |
| 45 | Madarosis | 20 | 5.9 | 5.9 | signal |
| 46 | Adrenal Insufficiency | 20 | 5.8 | 5.8 | signal |
| 47 | Blood Urea Increased | 28 | 5.8 | 5.8 | signal |
| 48 | Hyperbilirubinaemia | 17 | 5.7 | 5.7 | signal |
| 49 | Oesophagitis | 18 | 5.7 | 5.7 | signal |
| 50 | Disseminated Intravascular Coagulation | 23 | 5.6 | 5.7 | signal |
| 51 | Flank Pain | 15 | 5.6 | 5.6 | signal |
| 52 | Respiratory Distress | 41 | 5.1 | 5.2 | signal |
| 53 | Blood Bilirubin Increased | 40 | 5.1 | 5.1 | signal |
| 54 | Haematocrit Decreased | 29 | 5.0 | 5.1 | signal |
| 55 | Atelectasis | 14 | 5.0 | 5.0 | signal |
| 56 | Blood Sodium Decreased | 27 | 5.0 | 5.0 | signal |
| 57 | Lymphocyte Count Decreased | 25 | 4.9 | 4.9 | signal |
| 58 | Haemoglobin Decreased | 143 | 4.8 | 4.9 | signal |
| 59 | Transfusion | 14 | 4.6 | 4.6 | signal |
| 60 | Mental Status Changes | 37 | 4.6 | 4.6 | signal |
| 61 | Tachypnoea | 18 | 4.6 | 4.6 | signal |
| 62 | Proteinuria | 25 | 4.6 | 4.6 | signal |
| 63 | Product Use In Unapproved Indication | 323 | 4.6 | 4.8 | signal |
| 64 | Hepatomegaly | 13 | 4.6 | 4.6 | signal |
| 65 | Electrolyte Imbalance | 15 | 4.5 | 4.5 | signal |
| 66 | Urosepsis | 12 | 4.5 | 4.5 | signal |
| 67 | Multi-organ Failure | 22 | 4.3 | 4.4 | signal |
| 68 | Acute Respiratory Distress Syndrome | 22 | 4.3 | 4.3 | signal |
| 69 | Hypocalcaemia | 23 | 4.2 | 4.2 | signal |
| 70 | Septic Shock | 52 | 4.2 | 4.2 | signal |
| 71 | Interstitial Lung Disease | 58 | 4.2 | 4.2 | signal |
| 72 | Bacteraemia | 14 | 4.1 | 4.1 | signal |
| 73 | Hypoxia | 40 | 3.9 | 4.0 | signal |
| 74 | Clostridium Difficile Colitis | 12 | 3.9 | 3.9 | signal |
| 75 | Myelosuppression | 38 | 3.9 | 3.9 | signal |
| 76 | Sepsis | 124 | 3.8 | 3.9 | signal |
| 77 | Device Related Infection | 17 | 3.8 | 3.8 | signal |
| 78 | Hyponatraemia | 61 | 3.8 | 3.8 | signal |
| 79 | Pleural Effusion | 66 | 3.8 | 3.8 | signal |
| 80 | Inappropriate Antidiuretic Hormone Secretion | 11 | 3.7 | 3.7 | signal |
| 81 | Nephropathy Toxic | 12 | 3.7 | 3.7 | signal |
| 82 | Platelet Count Increased | 14 | 3.7 | 3.7 | signal |
| 83 | Blood Calcium Decreased | 12 | 3.7 | 3.7 | signal |
| 84 | Petechiae | 11 | 3.7 | 3.7 | signal |
| 85 | Disease Recurrence | 50 | 3.6 | 3.6 | signal |
| 86 | Epistaxis | 78 | 3.6 | 3.6 | signal |
| 87 | Body Temperature Increased | 21 | 3.6 | 3.6 | signal |
| 88 | General Physical Health Deterioration | 117 | 3.5 | 3.6 | signal |
| 89 | Respiratory Failure | 74 | 3.5 | 3.5 | signal |
| 90 | Intraocular Pressure Increased | 13 | 3.5 | 3.5 | signal |
| 91 | Fistula | 11 | 3.4 | 3.4 | signal |
| 92 | C-reactive Protein Increased | 35 | 3.3 | 3.3 | signal |
| 93 | Diarrhoea Haemorrhagic | 9 | 3.3 | 3.3 | signal |
| 94 | Candida Infection | 16 | 3.3 | 3.3 | signal |
| 95 | Pyrexia | 331 | 3.3 | 3.4 | signal |
| 96 | Colitis | 36 | 3.3 | 3.3 | signal |
| 97 | Pneumothorax | 15 | 3.3 | 3.3 | signal |
| 98 | Haematuria | 32 | 3.2 | 3.2 | signal |
| 99 | Blood Test Abnormal | 13 | 3.2 | 3.2 | signal |
| 100 | Accident | 11 | 3.2 | 3.2 | signal |
| 101 | Aspartate Aminotransferase Increased | 49 | 3.2 | 3.2 | signal |
| 102 | Ejection Fraction Decreased | 14 | 3.1 | 3.1 | signal |
| 103 | No Therapeutic Response | 11 | 3.1 | 3.1 | signal |
| 104 | Blood Alkaline Phosphatase Increased | 22 | 3.1 | 3.1 | signal |
| 105 | Central Nervous System Lesion | 12 | 3.0 | 3.0 | signal |
| 106 | Hypophagia | 22 | 3.0 | 3.0 | signal |
| 107 | Tachycardia | 77 | 3.0 | 3.0 | signal |
| 108 | Grand Mal Convulsion | 8 | 3.0 | 3.0 | signal |
| 109 | Sinus Tachycardia | 12 | 2.9 | 2.9 | signal |
| 110 | Alanine Aminotransferase Increased | 52 | 2.9 | 2.9 | signal |
| 111 | Full Blood Count Decreased | 17 | 2.9 | 2.9 | signal |
| 112 | Deafness | 22 | 2.9 | 2.9 | signal |
| 113 | Hepatic Failure | 25 | 2.9 | 2.9 | signal |
| 114 | Dehydration | 110 | 2.9 | 2.9 | signal |
| 115 | Hepatotoxicity | 18 | 2.8 | 2.8 | signal |
| 116 | Intestinal Obstruction | 30 | 2.8 | 2.8 | signal |
| 117 | Status Epilepticus | 9 | 2.8 | 2.8 | signal |
| 118 | Neoplasm | 9 | 2.7 | 2.7 | signal |
| 119 | Neutrophil Count Increased | 8 | 2.7 | 2.7 | signal |
| 120 | Pneumonitis | 21 | 2.7 | 2.7 | signal |
| 121 | Peritonitis | 16 | 2.7 | 2.7 | signal |
| 122 | Vomiting | 360 | 2.7 | 2.8 | signal |
| 123 | Blood Potassium Decreased | 23 | 2.6 | 2.7 | signal |
| 124 | Therapy Non-responder | 34 | 2.6 | 2.6 | signal |
| 125 | Staphylococcal Infection | 25 | 2.6 | 2.6 | signal |
| 126 | Respiratory Arrest | 21 | 2.6 | 2.6 | signal |
| 127 | Sudden Death | 8 | 2.6 | 2.6 | signal |
| 128 | Renal Failure Acute | 32 | 2.6 | 2.6 | signal |
| 129 | Blood Creatinine Increased | 48 | 2.5 | 2.6 | signal |
| 130 | Pulmonary Fibrosis | 14 | 2.5 | 2.5 | signal |
| 131 | Palmar-plantar Erythrodysaesthesia Syndrome | 17 | 2.5 | 2.5 | signal |
| 132 | Decreased Appetite | 167 | 2.5 | 2.5 | signal |
| 133 | Choking | 14 | 2.5 | 2.5 | signal |
| 134 | Blood Count Abnormal | 11 | 2.5 | 2.5 | signal |
| 135 | Renal Tubular Necrosis | 7 | 2.5 | 2.5 | signal |
| 136 | Drug Ineffective For Unapproved Indication | 39 | 2.4 | 2.4 | signal |
| 137 | Infection | 100 | 2.4 | 2.4 | signal |
| 138 | Abdominal Pain | 161 | 2.4 | 2.4 | signal |
| 139 | Stomatitis | 41 | 2.3 | 2.3 | signal |
| 140 | Cholecystitis | 8 | 2.3 | 2.3 | signal |
| 141 | Pulmonary Hypertension | 14 | 2.3 | 2.3 | signal |
| 142 | Haemorrhoids | 13 | 2.3 | 2.3 | signal |
| 143 | Eating Disorder | 14 | 2.3 | 2.3 | signal |
| 144 | Agranulocytosis | 12 | 2.2 | 2.2 | signal |
| 145 | Hepatic Function Abnormal | 24 | 2.2 | 2.2 | signal |
| 146 | Death | 556 | 2.2 | 2.4 | signal |
| 147 | Cyst | 8 | 2.2 | 2.2 | signal |
| 148 | Circulatory Collapse | 11 | 2.2 | 2.2 | signal |
| 149 | Leukaemia | 6 | 2.2 | 2.2 | no signal |
| 150 | Neurotoxicity | 11 | 2.2 | 2.2 | signal |
| 151 | Hypothyroidism | 20 | 2.2 | 2.2 | signal |
| 152 | Hypotension | 124 | 2.1 | 2.2 | signal |
| 153 | Blood Potassium Increased | 10 | 2.1 | 2.1 | signal |
| 154 | Encephalopathy | 15 | 2.1 | 2.1 | signal |
| 155 | Pericardial Effusion | 14 | 2.1 | 2.1 | signal |
| 156 | Lethargy | 34 | 2.0 | 2.1 | signal |
| 157 | Haematemesis | 15 | 2.0 | 2.0 | signal |
| 158 | Product Use Issue | 109 | 2.0 | 2.0 | signal |
| 159 | Depressed Level Of Consciousness | 23 | 2.0 | 2.0 | signal |
| 160 | Lung Neoplasm Malignant | 23 | 1.9 | 1.9 | no signal |
| 161 | Rectal Haemorrhage | 24 | 1.9 | 1.9 | no signal |
| 162 | Neuropathy Peripheral | 52 | 1.9 | 1.9 | no signal |
| 163 | Nausea | 432 | 1.9 | 2.0 | no signal |
| 164 | Transaminases Increased | 12 | 1.9 | 1.9 | no signal |
| 165 | Appendicitis | 5 | 1.9 | 1.9 | no signal |
| 166 | Off Label Use | 466 | 1.9 | 1.9 | no signal |
| 167 | Incorrect Route Of Product Administration | 9 | 1.9 | 1.9 | no signal |
| 168 | Cholestasis | 10 | 1.8 | 1.8 | no signal |
| 169 | Vaginal Haemorrhage | 22 | 1.8 | 1.8 | no signal |
| 170 | Pallor | 14 | 1.8 | 1.8 | no signal |
| 171 | Lymphadenopathy | 18 | 1.8 | 1.8 | no signal |
| 172 | Lung Infection | 8 | 1.8 | 1.8 | no signal |
| 173 | Cardiac Failure | 40 | 1.7 | 1.7 | no signal |
| 174 | Respiratory Depression | 6 | 1.7 | 1.7 | no signal |
| 175 | Drug Effect Incomplete | 18 | 1.7 | 1.7 | no signal |
| 176 | Paralysis | 7 | 1.7 | 1.7 | no signal |
| 177 | Disorientation | 19 | 1.7 | 1.7 | no signal |
| 178 | Convulsion | 27 | 1.6 | 1.6 | no signal |
| 179 | Genital Haemorrhage | 6 | 1.6 | 1.6 | no signal |
| 180 | Pelvic Pain | 8 | 1.5 | 1.5 | no signal |
| 181 | Treatment Failure | 36 | 1.5 | 1.5 | no signal |
| 182 | Abdominal Pain Lower | 11 | 1.5 | 1.5 | no signal |
| 183 | Erythema Multiforme | 4 | 1.5 | 1.5 | no signal |
| 184 | Cytomegalovirus Infection | 7 | 1.5 | 1.5 | no signal |
| 185 | Polyneuropathy | 5 | 1.5 | 1.5 | no signal |
| 186 | Therapeutic Response Decreased | 25 | 1.4 | 1.4 | no signal |
| 187 | Vaginal Discharge | 4 | 1.4 | 1.4 | no signal |
| 188 | Toxicity To Various Agents | 66 | 1.4 | 1.4 | no signal |
| 189 | Neoplasm Malignant | 26 | 1.3 | 1.4 | no signal |
| 190 | Sars-cov-2 Test Positive | 5 | 1.3 | 1.3 | no signal |
| 191 | Cytokine Release Syndrome | 7 | 1.3 | 1.3 | no signal |
| 192 | Alopecia | 69 | 1.2 | 1.2 | no signal |
| 193 | Local Swelling | 6 | 1.2 | 1.2 | no signal |
| 194 | Hepatic Cytolysis | 4 | 1.1 | 1.1 | no signal |
| 195 | Brain Neoplasm | 3 | 1.1 | 1.1 | no signal |
| 196 | Poor Quality Product Administered | 3 | 1.0 | 1.0 | no signal |
| 197 | Drug Administration Error | 8 | 0.9 | 0.9 | no signal |
| 198 | Hair Colour Changes | 3 | 0.8 | 0.8 | no signal |
| 199 | Hair Texture Abnormal | 3 | 0.8 | 0.8 | no signal |
| 200 | Diabetic Ketoacidosis | 5 | 0.7 | 0.7 | no signal |
| 201 | Device Failure | 3 | 0.7 | 0.7 | no signal |
| 202 | Colorectal Cancer | 9 | 0.6 | 0.6 | no signal |
| 203 | Device Leakage | 6 | 0.5 | 0.5 | no signal |